Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.
Borgogna C, Bruna R, Griffante G, Martuscelli L, De Andrea M, Ferrante D, Patriarca A, Mahmoud AM, Gaidano V, Marchetti M, Rapezzi D, Lai M, Pistello M, Ladetto M, Massaia M, Gaidano G, Gariglio M.
Borgogna C, et al. Among authors: de andrea m.
Blood Cancer J. 2022 Jan 18;12(1):8. doi: 10.1038/s41408-022-00608-6.
Blood Cancer J. 2022.
PMID: 35042847
Free PMC article.
Clinical Trial.